PER2 knockdown drives immunotherapy resistance in gastric cancer via metabolic reprogramming of myeloid-derived suppressor cells.
0/5 보강
APA
Zhan S, Lu S, et al. (2026). PER2 knockdown drives immunotherapy resistance in gastric cancer via metabolic reprogramming of myeloid-derived suppressor cells.. Cancer & metabolism. https://doi.org/10.1186/s40170-026-00424-7
MLA
Zhan S, et al.. "PER2 knockdown drives immunotherapy resistance in gastric cancer via metabolic reprogramming of myeloid-derived suppressor cells.." Cancer & metabolism, 2026.
PMID
41928364
같은 제1저자의 인용 많은 논문 (5)
- [Expression of Concern] MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.
- Intranasal immunization of recombinant vaccinia virus bearing FeLV SU elicits systemic and mucosal immunity.
- [Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance].
- Building and validating a machine learning-based survival prediction model for early gastric cancer: a SEER database analysis.
- Exploration of the Mechanism of Action of in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro Validation.